On Cancer

Search by keywords:

Show search filters

Explore by tags:

810 Blog posts found

In Memoriam

Memorial Sloan Kettering Mourns the Death of Cancer Research Pioneer Janet Rowley

Memorial Sloan Kettering President and CEO Craig Thompson reflects on the life and career of cancer research pioneer Janet Rowley.

Richard Barakat Appointed Deputy Physician-in-Chief for Memorial Sloan Kettering Regional Care Network and Alliances

Gynecological surgeon Richard Barakat will lead the network by expanding its presence in the New York metropolitan area while also building relationships and forming alliances with medical institutions outside the region.

Pictured: Richard R. Barakat,

Ask the Expert

Will I become addicted to the pain medications I may need during my cancer treatment?

Memorial Sloan Kettering physician Natalie Moryl discusses pain medications in cancer treatment and why patients should not avoid them due to fears of addiction.

Pictured: Natalie Moryl (Khojainova), MD


At Work: Immunologist Alexander Rudensky

Alexander Rudensky’s research focuses on the role of a subset of white blood cells called regulatory T cells, which are believed to suppress the immune system’s ability to fight tumors.

Pictured: Alexander Rudensky


When the Holiday Cheer Gets You Down: Eight Tips for Coping with Difficult Emotions

Clinical psychologist Wendy Lichtenthal offers advice to people with cancer and their loved ones, to whom "Happy Holidays" may ring hollow this year.

Pictured: Wendy Lichtenthal

In the Lab

Molecular Studies Explain Effectiveness of Longtime Treatment for Prostate Cancer

Laboratory studies have revealed an explanation for why androgen-deprivation therapy makes radiation therapy more effective in the treatment of high-risk prostate cancer.

Pictured: Charles L. Sawyers, William Polkinghorn & Simon Powell


Follow-Up Care Crucial for Pediatric Cancer Survivors

In this Q&A, pediatric endocrinologist Charles Sklar discusses Memorial Sloan Kettering’s Long-Term Follow-Up Program, which manages the health of pediatric cancer survivors.

Pictured: Charles Sklar

In the Clinic

New Diagnostic Test for Blood Cancers Will Help Doctors Tailor Treatments

A new diagnostic test co-developed by Memorial Sloan Kettering identifies hundreds of genetic alterations in blood cancers, which will guide physicians in treatment decisions.

Pictured: Ross Levine

In the News

New Biotech Startup Will Pit the Immune System Against Cancer

Memorial Sloan Kettering’s partnership in a pioneering effort to speed the development of cancer immunotherapies drew national headlines.

Pictured: Isabelle Rivière, Michel Sadelain & Renier Brentjens


Michael Foley Named Director of Tri-Institutional Therapeutics Discovery Institute

A renowned chemist with 25 years of industry and academic experience, Michael Foley will lead a pioneering collaboration designed to speed the development of new drugs for people with cancer and other diseases.

Pictured: Michael Foley